Which states are eligible for sublingual semaglutide?

Wisp can currently provide sublingual semaglutide to patients in the following states:

  • ALASKA
  • CALIFORNIA
  • COLORADO
  • DELAWARE
  • DISTRICT OF COLUMBIA
  • GEORGIA
  • HAWAII
  • IDAHO
  • ILLINOIS
  • IOWA
  • KANSAS
  • KENTUCKY
  • MAINE
  • MARYLAND
  • MASSACHUSETTS
  • MICHIGAN
  • MONTANA
  • NEBRASKA
  • NEVADA
  • NEW YORK
  • NORTH DAKOTA
  • OHIO
  • OREGON
  • RHODE ISLAND
  • UTAH
  • VERMONT
  • WYOMING
Did this answer your question? Thanks for the feedback There was a problem submitting your feedback. Please try again later.

Still need help? Contact Us Contact Us